Provider review
Knownwell review
Prices branded GLP-1s including Saxenda, and the pen costs far more than the vial.
None of the medication cards states a billing period, while a promotion beside them states its own.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Knownwell
$299 Zepbound vial · $349 Ozempic · $199 Saxenda, no period stated
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Not a compounded product
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
This is a branded-medication price list rather than a compounded program, and that changes what it is useful for. Everything named here is an FDA-approved product, so you are comparing against the manufacturers' own drugs rather than a compounding pharmacy's version, and the figures sit well below the list prices those products carry without help. What the page does not do is attach a period to any of them. The medication cards show an amount and nothing else, and the page proves this is a choice rather than an oversight, because a promotional line a few pixels away states its own term explicitly. Without a period the figures cannot be compared against anything monthly, which is most of this category. Two details are worth attention beyond that. The first is that the same drug is priced twice depending on the delivery device, with a pen costing substantially more than a vial of the identical medication — that difference buys convenience, not drug, and anyone drawing a deliberately small dose has more reason than most to take the vial. The second is Saxenda, which is branded liraglutide and therefore the only daily injection here. If your plan is to hold the smallest workable amount, a daily schedule gives finer control than any weekly product on this page.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want FDA-approved branded products rather than a compounded preparation
- You want a daily GLP-1, which among branded products means Saxenda
- You are drawing a small dose and would rather have a vial than a pen
Look elsewhere if
- You are comparing monthly rates. None of these figures states a period
- You want the convenience of a pen without paying a premium for the device
- You want a dose behind the number. None is published
What it actually costs
Price as published
A dedicated medication-pricing page listing branded products by name: Zepbound vial $299, Zepbound QwikPen $299 and Zepbound Pen $499; Ozempic $349; Saxenda $199; with program figures of $149 and $349 alongside them · none of the medication cards states a billing period, and the page demonstrates it states one where it means one — a promotional line reads "limited time offer for new patients: $199 for 2 months" — so the bare figures are not read here as monthly rates · the same molecule is priced two ways: a Zepbound pen costs $200 more than a Zepbound vial of the same drug, which is a device charge rather than a medication one and is worth knowing before choosing the more convenient format · ★ Saxenda is one of very few branded liraglutide products priced anywhere on this site, and liraglutide is the only daily GLP-1, which makes it the finest-grained option for holding a small dose · all three molecules appear — semaglutide, tirzepatide and liraglutide — as branded products rather than compounded ones · no dose is published
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. A branded-medication price list rather than a compounded program: every product named is FDA-approved, so a reader compares against the manufacturers' own drugs. ★ It includes SAXENDA, a branded liraglutide and the only DAILY GLP-1 here, which gives finer control over a small dose than any weekly product on the page. None of the medication cards states a billing period, and the page proves that is a choice rather than an oversight — a promotional line beside them states its own term explicitly — so nothing here is readable as a monthly rate. The same drug is priced twice by delivery device, with the pen costing substantially more than the vial of identical medication; that difference buys convenience, not drug. No dose published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Billed separately
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Branded products are named individually with their own figures on one page.
- Includes Saxenda, a branded liraglutide and the only daily GLP-1 listed here.
- The vial is priced below the pen, so the cheaper format is available and visible.
Pharmacy, labs and oversight
Knownwell dispenses through a Not applicable — branded, FDA-approved products facility. No bloodwork is required before you start. A clinician review is billed separately.
Transparency check
2 of 4 published openly
What Knownwell publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
This is a branded-medication price list rather than a compounded program, and that changes what it is useful for. Everything named here is an FDA-approved product — Zepbound, Ozempic, Saxenda — so a reader is comparing against the manufacturers' own drugs rather than against a compounding pharmacy's version, and the figures sit well below the list prices those products carry without help. What the page does not do is attach a period to any of them. The medication cards show an amount and nothing else, and the page proves this is a choice rather than an oversight, because a promotional line a few pixels away states its own term explicitly. Without a period the figures cannot be compared against anything monthly, which is most of this category. Two details are worth a reader's attention beyond that. The first is that the same drug is priced twice depending on the delivery device, with a pen costing substantially more than a vial of the identical medication — that difference buys convenience, not drug, and anyone drawing a deliberately small dose has more reason than most to take the vial. The second is Saxenda, which is branded liraglutide and therefore the only daily injection here. For someone whose plan is to hold the smallest workable amount, a daily schedule gives finer control than any weekly product on this page.
The honest cons
None of the medication figures states a billing period.
- The same drug costs substantially more in a pen than in a vial.
- No dose is published behind any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Knownwell is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#267 of 373
Ordered with the companies that pay us first, and Knownwell is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- Microdosing from a pen
- The true annual cost of a plan
- Microdose & reconstitution calculator
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.